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ABSTRACT
Traffic-related air pollution (TRAP) affects approximately 45 million individuals who live
within 300 feet of a major highway, resulting in adverse respiratory and cardiovascular outcomes
(e.g., asthma, inflammation). Recent studies indicate that green infrastructure reduces aerosol
concentrations and potentially limits TRAP-related toxicity. We hypothesized that green
infrastructure might mitigate reactive oxygen species (ROS) generation, oxidative stress, cytokine
secretion, and potential inflammation and injury in human primary small airway epithelial cells
(SAEC) associated with similar respiratory pathologies, including asthma. TRAP was monitored
at five Atlanta locations (S1: green barrier; S2: no barrier; S3: combination barrier; S4: no barrier;
S5: green barrier) next to and behind barriers using continuous instrumentation, and sampled
particulate matter (PM) was collected on pre-weighed polytetrafluoroethylene (PTFE) filters. The
collected PM was extracted and prepared for toxicological assessments, including CellROX®,
total glutathione (GSH), and MTS assays, which measured ROS production, oxidative stress, and
cellular viability, respectively, using SAEC following a 48-hour exposure period. Additionally,
the Human Cytokine Array Proinflammatory Focused 15-plex (HDF15) was used to evaluate the
secretion of pro-inflammatory cytokines, such as granulocyte-macrophage colony-stimulating
factor (GM-CSF), interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and tumor
necrosis factor-alpha (TNF-). Preliminary in vitro toxicological analyses revealed that sites with
green barriers (e.g., S1, S5) decreased TRAP-induced impacts on oxidative stress and cytokine
secretion in SAEC. However, there was no reduction in cell viability following PM exposures.
Additionally, a site with a combination barrier (e.g., S3) decreased GM-CSF, IL-8, and TNF-
cytokine secretion in SAEC. TRAP exposures may elicit harmful pulmonary mechanisms,
including inflammation and oxidative stress in lung epithelial cells over time. This work suggests
green barriers may influence the biological activity of PM. In sum, green barriers may play a role
in mitigating TRAP-mediated respiratory health effects.
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1. INTRODUCTION
Air pollution refers to the release of pollutants into the environment that harms human
health, resulting in adverse respiratory, cardiovascular, and biological outcomes. The U.S.
Environmental Protection Agency (EPA) continuously monitors and regulates air quality trends
using criteria pollutants, including carbon monoxide (CO), lead, nitrogen dioxide (NO 2), ozone,
particulate matter (PM2.5 and PM10), and sulfur dioxide (SO2). Traffic-related air pollution (TRAP)
refers to air pollution derived from motor vehicle emissions following fossil fuel combustion. In
other words, TRAP encompasses combustion emissions (contributed primarily by on-road diesel
and gasoline vehicles), secondary pollutants formed in the atmosphere, such as inorganic and
organic molecules, and non-combustion emissions, including but not limited to road dust and
brake/tire wear (Matz et al., 2019). TRAP exposures have been implicated in several adverse health
outcomes, including premature mortality (Jerrett et al., 2009), cardiovascular outcomes (Brook et
al., 2010; Cesaroni et al., 2014; Lanki et al., 2006; Link & Dockery, 2010), cerebrovascular
outcomes (Stafoggia et al., 2014), respiratory outcomes (Gasana et al., 2012; Gehring et al., 2010;
Lindgren et al., 2009; MacIntyre et al., 2014), reproductive outcomes (Brauer et al., 2008; Yorifuji
et al., 2016), and neurological as well as cognitive disorders (Power et al., 2016; Raz et al., 2015).

Vulnerable subpopulations, including but not limited to young children (Clark et al., 2010;
Clifford et al., 2018; Gasana et al., 2012; McConnell et al., 2010), the elderly (Delphino et al.,
2014), racial/ethnic groups (Apelberg, Buckley, & White, 2005; Park & Kwan, 2020; Tian, Xue,
& Barzyk, 2012), and socioeconomically deprived individuals (Apelberg, Buckley, & White,
2005; Chi et al., 2016; O’Neill et al., 2003; Tian, Xue, & Barzyk, 2012) across the U.S., are
susceptible to TRAP exposures (Hooper & Kaufman, 2018; Makri & Stilianakis, 2008). These

1

subpopulations are exposed to TRAP due to their proximity to major highways/roadways as well
as intersections of major roads and certain underlying diseases, such as asthma (Clark et al., 2010;
Clifford et al., 2018; Gasana et al., 2012; McConnell et al., 2010), hypertension (Delphino et al.,
2014; Brook et al., 2009; Kaufman et al., 2016), and lung cancer (Apelberg, Buckley, & White,
2005; Churg et al., 2003; Health Effects Institute, 2010). Acute and chronic exposures to PM
components of TRAP, specifically ultrafine particles (UFPs), and their associated toxicological
properties, however, remain to be thoroughly investigated. Potential interventions and strategies
that may reduce TRAP exposures for susceptible subpopulations include investing in green
infrastructure (i.e., trees, vegetation; Amorim et al., 2013; Brugge et al., 2015), investing in biking
and walking trails in neighborhoods within urban cities (Brugge et al., 2015) and developing
alternate public transportation options appropriate for all individuals (Xia et al., 2015).

We aim to address the following experimental questions: 1) What is the toxicological
impact of traffic-related UFP concentrations on the respiratory system? 2) What TRAP properties
mediate adverse cellular outcomes? 3) Can green infrastructure help mitigate or reduce these
observed cellular effects? We hypothesize that green infrastructure may mitigate ROS generation,
oxidative stress, cytokine secretion, and potential inflammation and injury in human primary small
airway epithelial cells (SAEC) associated with respiratory pathologies such as asthma. An in vitro
dose-response analysis using cellular bioassays, including the CellROX®, total glutathione (GSH),
and MTS assays, was performed to measure ROS production, oxidative stress, and cellular
viability, respectively. The Human Cytokine Array Pro-inflammatory Focused 15-plex (HDF15)
from Eve Technologies (Alberta, Canada) was used to test for the following cytokines:
granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon gamma (IFN),
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interleukin-1 (IL-1), IL-1ra, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12(p40), IL-12(p70),
monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor-alpha (TNF-). Lastly,
a one-way ANOVA analysis involving Tukey’s post-hoc test and descriptive statistics were
utilized to relate sampling location and UFP concentrations to all cellular outcomes, such as ROS
generation, subsequent oxidative stress, antioxidant capacity, cellular viability, and cytokine
secretion in SAEC.
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2. REVIEW OF THE LITERATURE
2.1 Historical Overview of Air Pollution in the U.S.
Substandard air quality contributes to adverse health outcomes, leading to increased
morbidity, mortality, and global disease burden (Samek, 2016). Since the Clean Air Act passage
in the year 1970, air quality in the U.S. has significantly improved, as shown by the reduction of
concentrations among all criteria air pollutants (since the 2000s for PM 2.5; U.S. EPA, 2020).
Among the several emissions sources (e.g., stationary fuel combustion, industrial and other
processes), highway vehicles emit mainly CO and NO2, followed by volatile organic compounds,
PM2.5, PM10, and SO2 being the lowest concentration (Sohrabi, Zietsman, & Khreis, 2020; U.S.
EPA, 2019; U.S. EPA 2020).

Air-pollutant concentrations are not distributed equally across the U.S. or within cities.
Factors that influence air quality differences include urban and rural settings, socioeconomic status
(i.e., lower-income versus higher-income), and race/ethnicity. Ingram and Franco (2014) examined
the 2013 urban-rural county categorization scheme, ranging from metropolitan to nonmetropolitan
counties. Metropolitan (“metro”) counties include large central metro counties (consisting of
1,000,000 or more individuals), large fringe metro counties (consisting of 1,000,000 or more
individuals that do not qualify as large central metro counties), medium metro counties (consisting
of 250,000 to 999,999 individuals), and small metro counties (consisting of less than 250,000
individuals). Nonmetro counties include micropolitan counties (consisting of 10,000 to 49,999
individuals) and noncore counties (i.e., nonmetro counties that do not qualify as micropolitan
counties). Nearly 31% of U.S. citizens live in urban counties (Strosnider et al., 2017). In contrast,
about 6% of U.S. citizens live in rural counties or county-equivalents (i.e., nonmetro counties
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containing fewer than 10,000 people; Strosnider et al., 2017). Two hundred eighty-six (286)
counties transitioned to a different county category assignment (i.e.., from a less urban metro
county to a more urban metro one, from a nonmetro county to a metro one) between 2006 and
2013 (Ingram & Franco, 2014). People residing in a rural county or county-equivalent, on average,
experienced 8.87 micrograms per cubic meter (g/m3) in PM2.5 concentrations compared to 11.15
g/m3 in urban counties between 2008 and 2012 (Strosnider et al., 2017).

The United Nations estimates that 68% of the world’s population will reside in urban
settings by 2050 (2014). The U.S. Bureau of Transportation Statistics reported a 1% increase in
the total number of registered highway vehicles (roughly 2,900,000 vehicles) between 2018 and
2019 (n.d.). Between 2018 and 2019, the nation’s population grew by approximately 1,500,000
people (0.5% increase; U.S. Census Bureau, 2019). States depend on census information to
distribute revenue from taxes to undergo significant local-road expansions and renovations
(America Counts Staff, 2019) to accommodate increased vehicular activity and alleviate traffic.
Construction projects like these, however, generate increased air pollutant concentrations since
vehicular activity remains relatively the same or increases following road expansion (Font et al.,
2014).

2.1.1 Disparities in Pollution Concentrations
Jorgenson and colleagues (2020) reviewed the power, proximity, and physiology
principles, suggesting that vulnerable populations’ exposure to ambient air pollution increases as
income inequality increases in terms of economic or political influence, geographical space, or
underlying physiological conditions, respectively (Hill et al., 2019). The three-way interaction
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between power, proximity, and physiology occurs at an amplified rate in states exhibiting higher
income-inequality levels and states with larger minority populations. Blacks and Hispanics
residing in urban settings typically live in more polluted cities and neighborhoods within those
cities than their Asian and White counterparts (Ash & Fetter, 2004; Gray, Edwards, & Miranda,
2013). Racial/ethnic disparities highlighted by geographic location (i.e., urban versus rural or
proximity to a major highway/roadway) and income inequality reveal differences in air pollution
exposure rates. Tessum and colleagues (2019) analyzed how primarily industrial fuel combustion,
followed by recreational and residential fuel combustion (e.g., operating recreational vehicles,
barbecuing), negatively impact Blacks and Hispanics compared to non-Hispanic Whites. After
adjusting for race/ethnicity to match other racial/ethnic groups without modifying consumption
rates, Blacks were exposed to at least two times the PM 2.5 concentration experienced by the overall
population (Tessum et al., 2019).

Compared to their non-Hispanic White counterparts, Blacks and Hispanics contribute little
to the average PM2.5 pollution levels yet experience at least 21% higher exposure (for Blacks) and
12% higher exposure (for Hispanics; Tessum et al., 2019). According to Tessum and colleagues,
total exposure emissions include but are not limited to road dust, residential gas and wood
combustion, construction, and agriculture. Pollution inequities, or the differences between the
environmental health damage caused by a racial-ethnic group and the damage that group
experiences, via differences in consumption trends highlight the racial disparities endured by
Blacks and Hispanics compared to their non-Hispanic White counterparts. After normalizing the
magnitude effect (i.e., the total amount of consumption), however, Blacks and Hispanics are
exposed to increased PM2.5 levels than non-Hispanic Whites (Tessum et al., 2019).
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2.2 Traffic-Related Air Pollution and Mitigation Measures
Approximately 45 million individuals live, work, and attend school within 300 feet of
major roadways (U.S. EPA, 2020), resulting in adverse health effects (e.g., respiratory,
cardiovascular, reproductive) due to TRAP exposures (Nuvolone et al., 2011). Depending on a
location’s infrastructure and meteorology, TRAP concentrations can vary spatially and temporally
(Cheng et al., 2019). Due to the inadequate information regarding traffic-source contribution to
TRAP and the limited ability to collect and monitor air pollutants, however, it proves challenging
to measure spatial and temporal variations in TRAP accurately (Batterman, Ganguly, & Harbin,
2015; Health Effects Institute, 2010; Wang et al., 2013). Generally, the summer months in the U.S.
(June, July, and August) are typically dominated by secondary aerosols formed through gas-toparticle conversion compared to the winter months (December, January, and February), which are
usually dominated by primary aerosols introduced directly into the air (Cheng et al., 2019). Current
evidence shows that increased TRAP levels persist near major highways/roadways and
intersections of major roads. Similarly, spatial and temporal variations in TRAP occur due to
distinct urban structures and traffic modes that lead to different pollutant distribution patterns over
time (Wang et al., 2013).

Enacting emission reduction policies, limiting TRAP exposures, and installing porous
(e.g., trees, vegetation) and solid barriers (e.g., noise walls, low-boundary walls) may present as
viable options to mitigate TRAP exposures (Gallagher et al., 2015). After introducing TRAP
reduction methods, such as motor vehicle emission standards (Lurmann, Avol, & Gilliland, 2015),
increasing active transportation usage (e.g., cycling) to minimize vehicular activity (Carlsten et al.,
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2020; Raza et al., 2018), shortening the time spent outside near major highways/roadways
(Carlsten et al., 2020; Laeremans et al., 2018), and investing in green infrastructure (Baldauf, 2016;
Gallagher et al., 2015; Hewitt, Ashworth, & MacKenzie, 2020; Litschke & Kuttler, 2008), air
pollutant concentrations have been shown to decrease over time.

Lurmann, Avol, and Gilliland examined motor vehicle emission standards in California by
measuring ambient criteria-pollutant concentrations (e.g., ozone, NO2, PM2.5, PM10) between 1993
and 2012 and obtaining emission policy information from a regulatory database (2015). The
researchers discovered that criteria-pollutant concentrations significantly decreased (i.e., an
approximately 3% decrease for ambient PM2.5 concentrations) due to declines in motor vehicle
emissions via reduction standards (Lurmann, Avol, & Gilliland, 2015). Raza and colleagues
performed a risk assessment to compare the relative risks (i.e., the ratio of the risks for an event
for the exposure group to the risks for an event for the non-exposure group) from previous studies
that examined shifts in transportation modes, such as the transition from motorized travel to
cycling (2018). While the researchers only examined eighteen studies in their review, they
determined that the general population’s health benefits and the commuters’ health risks
undervalue the effect of vehicle exhaust exposure even though car users experienced 1.16 to 1.6
times higher PM2.5 concentrations than cyclists (Raza et al., 2018).

Hewitt, Ashworth, and MacKenzie reviewed how trees and other vegetation barriers (i.e.,
green barriers) can protect individuals by creating natural shields against TRAP or redirecting
airflow above the green barriers, suggesting how developing green spaces can effectively reduce
TRAP levels to improve urban air quality ultimately (2020). Gallagher and colleagues noted that
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urban infrastructure (i.e., barrier/street geometry and roadway layout) plays a significant role in
mitigating air pollution (2015). Combining porous and solid barriers to optimize the effect of
reducing air pollution in urban locations, particularly near major highways/roadways, can offer a
quality solution compared to either installed barrier alone (Gallagher et al., 2015).

Jayasooriya and colleagues explored the impact green infrastructure, specifically trees,
green roofs, green walls, and a combination of any of the previously mentioned scenarios (i.e.,
trees and green roofs, trees and green walls, green roofs and green walls), has on urban air quality
and other factors in several cities, including but not limited to Atlanta, GA, New York, NY,
Baltimore, MA, and Philadelphia, PA (2017). Besides the environmental factors, such as annual
pollutant removal, other factors included economic costs and savings as well as social livability
improvement (Jayasooriya et al., 2017). Two scenarios – trees and green roofs and trees and green
walls – provided increased protection against TRAP, particularly PM 2.5 and PM10, compared to
any other presented scenario alone (Jayasooriya et al., 2017). Trees and green roofs as well as
green roofs and green walls resulted in increased annual building energy savings and lowered
capital costs and annual operation and maintenance costs (Jayasooriya et al., 2017). Trees and
green roofs also improved social livability, followed closely by trees and green walls (Jayasooriya
et al., 2017).

2.3 U.S. Air Quality Regulations
The University of Washington Institute for Health Metrics and Evaluation reported that
PM is accountable for nearly 60% of deaths from environmental causes (2016). PM contains
minuscule solids or liquid droplets that individuals can inhale, leading to adverse health outcomes.
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PM particles, typically formed by chemical reactions with atmospheric traffic-related air pollutants
(also known as secondary pollutants), can differ in aerodynamic diameter: coarse PM 10 (particles
that measure less than 10 micrometers in diameter), fine PM 2.5 (particles that measure less than 2.5
micrometers in diameter), and PM0.1 (particles that measure less than 0.1 micrometers in diameter).
The PM size determines where particles will accumulate in the human body (i.e., the upper
respiratory tract [URT] for PM10, the tracheobronchial regions for PM2.5, the distal alveolar regions
for PM0.1). The URT includes the nose and mouth. The tracheobronchial regions refer to the airway
between the trachea and terminal bronchioles in the lungs. Distal alveolar regions are where gas
exchange occurs that cross the blood barrier into other organs throughout the body. Particle
diameter negatively correlates with associated toxicity and lung deposition (i.e., increased toxicity
occurs following exposure to smaller PM sizes, and the size dictates where in the body the particles
will deposit). PM10 is filtered in the proximal airway (i.e., the URT), which may irritate the skin
and mucosa. PM2.5 can reach the peripheral airway (i.e., the tracheobronchial regions) but cannot
enter the systemic circulation. Due to its large surface area, PM0.1 can adsorb toxic chemicals,
including elemental and organic carbon, water-soluble ions, and other trace elements (e.g.,
polycyclic aromatic hydrocarbons [PAHs]), on its surface, which may enter the systemic
circulation (Chen et al., 2010; Haghani et al., 2020; Kwon, Ryu, & Carlsten, 2020). Desorption of
these toxic chemicals and PM0.1 cellular interactions can result in a dual exposure, which may
exacerbate or increase adverse health effects (Chen et al., 2010; Haghani et al., 2020; Kwon, Ryu,
& Carlsten, 2020).

PM0.1 particles (also known as UFPs) have been linked to unfavorable respiratory effects,
including but not limited to asthma, chronic obstructive pulmonary disease (COPD), emphysema,
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and lung cancer (Clifford et al., 2018; Health Effects Institute, 2010). While researchers
continuously assess how PM2.5 and PM10 adversely affect human health, limited knowledge exists
on how PM0.1 leads to decreased respiratory function since no standards are present for PM smaller
than 2.5 micrometers in diameter. It is known, however, that UFPs contain unusually high amounts
of elemental and organic carbon in the form of black carbon (BC) as well as PAHs, carbonyl
compounds, n-alkanes, organic acids, and heterocyclic compounds, respectively, among other
chemicals and molecules (Chen et al., 2010; Kwon, Ryu, & Carlsten, 2020). Previous studies have
reported the adverse health effects caused by elemental and organic carbon (Kelly & Fussell, 2012;
Ostro et al., 2008; Ostro et al., 2009).

According to the Clean Air Act, a U.S. federal law designed to protect human health and
the environment from air pollution effects, the EPA must regulate pollutant emissions that harm
public health and welfare. To do this, the EPA continuously updates primary and secondary
National Ambient Air Quality Standards (NAAQS) for criteria pollutants (2016). Primary
standards establish limits to protect vulnerable populations’ health, whereas secondary standards
set limits to protect the environment. Currently, primary and secondary standards for PM 2.5 and
PM10 require annual average standards (primary standard for PM2.5: annual mean, averaged over
three years, of 12.0 g/m3; secondary standard for PM2.5: annual mean, averaged over three years,
15.0 g/m3) and daily standards (primary and secondary standards for PM 2.5: 98th percentile,
averaged over three years, of 35 g/m3; primary and secondary standards for PM10: not to exceed
150 g/m3 more than once per year on average over three years).
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PM0.1 and PM2.5 concentrate near highways, dependent on roadway layout, traffic volume,
vehicle type, and atmospheric conditions. Kuwayama, Ruehl, and Kleeman observed five different
conditions in which PM0.1 mass concentrations increased in downtown Sacramento, California: old
diesel engines, residential wood smoke, rails, regional traffic (i.e., gasoline and diesel engines),
and brake wear/paved road dust (2013). In addition to measuring PM 0.1 mass, PM0.1 composition
was also determined to pinpoint which chemicals (i.e., elemental and organic carbon, sulfur, and
other trace elements) exhibited high levels within the collected PM 0.1 (Kuwayama, Ruehl, &
Kleeman, 2013). Chemicals adsorbed onto UFP surfaces pose a serious health risk for individuals
inhaling them. This study further supports the need for emissions standards and other practical
mitigation efforts since older (diesel) engines, on average, contributed to approximately 25% of
total PM0.1 concentrations (Kuwayama, Ruehl, & Kleeman, 2013). Previous studies have suggested
vehicular activity contributes to 20% of PM2.5 variation (i.e., changes in concentration,
spatiotemporal changes; Milando, Huang, & Batterman, 2016; Morishita et al., 2006).

Historically, PM monitoring and sampling have been used to investigate TRAP exposures,
determine the air quality in a country or region, and assess several mitigation strategies’
effectiveness. Standard PM monitoring methods include but are not limited to continuous mass
monitoring, such as opacity monitors, light-scattering technologies, and tapered-element
oscillating microbalance (TEOM; Wilson et al., 2002). The objective of continuous mass
monitoring includes measuring real-time PM mass found in ambient air (Solomon & Sioutas,
2008). Opacity monitors, such as microaethalometers which measure BC, quantify the extent to
which PM reduces light transmission (Eiseman, 1998). Microaethalometers are easy to operate,
only requiring TeflonTM coated glass fiber filter media. Among other optical PM monitoring
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methods, however, opacity devices are the least sensitive due to a minor measurable change in
light transmission in a considerable amount of emission (Eiseman, 1998). Light-scattering
technologies account for PM composition, size distribution, and volume to observe particle loading
by measuring the light reflected from the particles’ surfaces forwards, backwards, and sideways.
Forward-, backward-, and side-scattering technologies range in sensitivity from worst to best,
respectively. However, these technologies are expensive, and all scattering methods require
calibrations to function correctly. TEOM directly measures PM mass by relating it to the mass’s
frequency output, which exhibits a negative correlation (i.e., as the mass increases, the frequency
output decreases and vice versa). While TEOM is sensitive to all particles, it is challenging to
control the humidity and temperature while using this method.

Standard PM sampling methods, such as the gravimetric (weighing) method using filters,
measure its concentration. In the gravimetric method, particles agglomerate onto a pre-weighed
filter, and the filter is reweighed following collection. This method’s advantage includes the ability
to chemically analyze the collected particles (Nussbaumer et al., 2008; Whalley & Zandi, 2016).
However, the gravimetric method does not offer data outside of the period in which the filter was
stationed. Additionally, this method requires accurate weighing, and an imprecise weighing
procedure can negatively influence measurements (i.e., measurements can vary between
weighings). PM collected on filters can be extracted into an aqueous solution using methanol
(MeOH), water, dichloromethane (DCM), and dimethylsulfoxide (DMSO; Roper et al., 2020).
Water and MeOH yield the highest concentrations compared to other solvents (Roper et al., 2020).

2.4 TRAP-Associated Adverse Health Outcomes, Cellular Responses, and Biomarkers
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TRAP exposures have been linked to adverse respiratory (Ostro et al., 2009; Sydbom et
al., 2001; Vimercati, 2011), cardiovascular (Brook et al., 2004; Ostro et al., 2008), reproductive
(Brauer et al., 2008), and biological/genetic (De Prins et al., 2013; Ji & Khurana Hershey, 2013)
outcomes. Harmful respiratory outcomes resulting from TRAP exposures can include but are not
limited to asthma (Ostro et al., 2009; Clifford et al., 2018), bronchitis (Lindgren et al., 2009),
COPD (Andersen et al., 2011; Ling & van Eeden, 2009), emphysema (Wang et al., 2019), and
lung cancer (Beelen et al., 2008; Chen et al., 2015). Susceptible subpopulations, including but not
limited to young children, the elderly, and specific racial/ethnic groups, are more at-risk for TRAPassociated adverse respiratory effects and outcomes due to age and related physiological
differences in inhalation rates (U.S. EPA, 2011), underdeveloped immune and respiratory systems
mainly in young children (Bowatte et al., 2015; Deng et al., 2016), and existing comorbidities
primarily in the elderly (de Hartog et al., 2003; Delphino et al., 2014).

TRAP exposures have been known to promote reactive oxygen species (ROS) generation
(Lakey et al., 2016; Venkatachari & Hopke, 2008; Verma et al., 2015), increase oxidative stress
(Bräuner et al., 2007; Møller & Loft, 2010; Risom, Møller, & Loft, 2005), decrease antioxidant
capacity (Cosselman et al., 2020) and cellular viability (Li et al., 2017; Wu et al., 2017), as well
as induce cytokine secretion (Boland et al., 2000; Sawyer et al., 2010; Silbajoris et al., 2011). ROS,
including but not limited to superoxide, hydrogen peroxide (H2O2), and hydroxyl radical, refer to
oxygen-containing reactive species. ROS form endogenously due to underlying chemical reactions
during mitochondrial oxidative phosphorylation or exogenously via interactions with foreign
compounds (i.e., xenobiotics) entering the cell (Ray, Huang, & Tsuji, 2012). Overproduction of
ROS can affect protein function by damaging RNA, mutate DNA to lead to cellular dysfunction,
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deplete ATP reserves, and inhibit apoptosis (i.e., programmed cell death) by directly oxidizing
relevant compounds and molecules (Risom, Møller, & Loft, 2005; Rosanna & Salvatore, 2012).
ROS have also been linked to cancer initiation and development (Cichon & Radisky, 2014).
Oxidative stress occurs when excess ROS or oxidants overwhelm a cell’s antioxidative defenses
(Ray, Huang, & Tsuji, 2012), potentially leading to cellular inflammation and injury. The cell’s
resulting antioxidant capacity, or its ability to protect against the oxidative damage done to it,
declines. When toxic insults occur, the cell cannot protect itself against incoming damage,
resulting in a higher number of damaged or dying cells within a population (i.e., diminished cell
viability). Cellular viability refers to the number of healthy cells in a sample.

Pro-inflammatory cytokines and chemokines that mediate the cell’s innate immunological
response to toxic insults can include but are not limited to granulocyte-macrophage colonystimulating factor (GM-CSF), interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1),
and tumor necrosis factor-alpha (TNF-), which are mainly produced by activated macrophages
and monocytes (Zhang & An, 2007). GM-CSF is a monomeric glycoprotein secreted by
macrophages and T helper cells that induces the recruitment and migration of cells to inflammation
sites, promotes survival of target cells, and stimulates granulocyte- and macrophage-regeneration
(Zhang & An, 2007). IL-8 is a chemotactic factor that recruits neutrophils, basophils, and T-cells
to inflammation sites and can be secreted by several structural and immune cells, including
bronchial epithelial cells, macrophages, and smooth muscle cells (Zhang & An, 2007). MCP-1
(also known as CCL2) is a chemotactic factor that recruits monocytes to inflammation sites and is
produced by various cell types following induction by oxidative stress, cytokines, or growth factors
(Deshmane et al., 2009). Macrophages and monocytes produce TNF- during the inflammatory
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process, which recruits other immune cells to the damaged site via signaling and can elicit
apoptosis and necrosis (i.e., localized death of living tissue; Zhang & An, 2007).

Typical in vitro bioassays detecting ROS production can include but are not limited to the
CellROX® and ROS-GloTM H2O2 assays that use stains and luminescence, respectively, to
examine the effects of oxidative stress on exposed cells. The CellROX® assay (Invitrogen,
California, U.S.) can employ the Oxidative Stress Orange Reagent, a cell-permanent dye that
exhibits bright orange fluorescence upon oxidation by ROS. In contrast, the ROS-GloTM H2O2
assay (Promega, Wisconsin, U.S.) utilizes an H 2O2 substrate that reacts with a luciferin precursor
to produce luciferin that emits a light signal proportional to the level of H 2O2. Other methodologies
detecting ROS production can include the comet and DTT assays (Jantzen et al., 2012; Jiang et al.,
2019). A commonly-used in vitro bioassay detecting oxidative stress can include but is not limited
to the GSH/GSSG-GloTM Assay (Promega, Wisconsin, U.S.) that detects and quantifies the
antioxidant glutathione (GSH), a relevant component in cellular metabolism, and other related
compounds (e.g., glutathione disulfide [GSSG]) in exposed cells. Another methodology detecting
oxidative stress includes the antioxidant depletion assay (Crobeddu et al., 2020). Standard in vitro
bioassays assessing cellular viability can include but are not limited to the MTS and MTT assays
(Promega, Wisconsin, U.S.), which measure metabolic activity by introducing a soluble
tetrazolium salt to the cells and observing whether or not it is metabolized. Another method
assessing cellular viability includes the LDH (lactate dehydrogenase) assay, which determines
irreversible cell death by examining whether or not membrane damage has occurred depending on
how much cytoplasmic lactate has been released from damaged or dying cells (Thomson et al.,
2015).
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3. METHODS AND PROCEDURES
3.1 TRAP Sampling Campaign
The data sampling collection campaign was designed to measure relative UFP numbers,
particle-size distributions, and total mass concentrations during peak traffic periods between July
and September 2020. Daily sampling occurred at times with increased traffic pollutant emissions
in the morning and afternoon (from 7 am to 3 pm). Each sampling day began the same, with
instrumentation set-up occurring first. Continuous instruments, including condensation particle
counters (CPC model 3007, TSI Incorporated, Minnesota, U.S.), microaethalometers
(microaethalometer model AE51, AethLabs, California, U.S.), microsensors that used a Plantower
PM2.5 PMS3003 particle counter (Duke University, North Carolina, U.S.), a NanoScan Scanning
Mobility Particle Sizer (NanoScan SMPS model 3910), an Optical Particle Sizer (OPS model
3330, TSI Incorporated, Minnesota, U.S.), Vantage Pro 2 or Vantage Vue weather station (Davis
Instruments, California, U.S.) as well as one Hobo weather station (Onset, Massachusetts, U.S.)
were set up near selected green barriers and roadways (Figures 1, 2). Each site consisted of two
sampling locations at least 20 meters (m) apart when continuous and integrated sampling took
place. Weather stations were placed on-site to collect data on wind speed, wind direction,
temperature, and relative humidity (Figure 2).

At the start and end of each sampling day, the CPCs, microaethalometers, and microsensors
were turned on simultaneously to initiate side-by-side sampling, ensuring that the continuous
instruments reported the same data points. Unlike the CPCs, microaethalometers, and
microsensors, the NanoScan SMPS and OPS instruments were not used during side-by-side
sampling in the morning and afternoon since only one instrument was used. Instrumentation was
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initially placed on a mobile cart for side-by-side sampling, and identical instruments were later
placed at both roadway and barrier locations. For those sites with no barriers (S2 and S4),
instruments were placed at least 20 m apart. Any issues with instrumentation (e.g., depleted
batteries) or suspected reasons for unusually high readings (e.g., vehicular idling) were
documented on a log sheet throughout the sampling day. Other pertinent information, such as
sample IDs, instrumentation start and end times, and initial and ending flow rates for the cascade
particle impactors constructed in our laboratory (Figure 2) used to collect PM on
polytetrafluoroethylene (PTFE) filters, was also recorded. A total of twelve sampling days were
completed at five distinct Atlanta locations: S1-S5 (Figure 3; Tables 1, 2). Green barriers were
present at S1 and S5, and a combination barrier (i.e., trees, sound wall) was present at S3. No
barriers were present at S2 and S4. In the “Road versus Barrier” column of Tables 1 and 2, “NA
(Front-Road/Side-Road)” indicates where the filter was collected since S2 and S4 did not contain
barriers (i.e., not applicable). Site locations varied by roadway layout and traffic volume.

PM1.0 mass, which included particles from the ultrafine range up to 1.0 micrometers in
diameter, was collected on four pre-weighed PTFE filters using cascade impactors during each
sampling day. After setting up two cascade impactors (one at the green barrier and the other at the
roadway or, if no barrier was present, both at the roadway 200 m apart) that each collected PM
mass on two separate filters, flow rates were measured, confirming a rate of 30 Liters/minute.
Following sample collection, filters were transported back to the laboratory and left in a desiccator
to equilibrate for 24 hours to a temperature of 25C and 15% relative humidity. Filters with any
leftover static charge were dissipated using a U-electrode (Mettler Toledo model 11140161) and
then weighed with a Mettler Toledo microbalance (model XS3DU) following Georgia State
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University (GSU) approved safety measures and protocols. Each sample was weighed at least two
times, ensuring that the weight did not differ more than 5 g between weights. Laboratory blanks
and field blanks (at least one filter for each site) were weighed using the same protocol. Laboratory
blanks were left in the desiccator during the sampling campaign. Field blanks were left in a box
used to transport filters during sampling.

3.2 PTFE Filter Extraction
Each PTFE filter was extracted using 5 milliliters (mL) of 75% MeOH. 75% MeOH was
prepared in different amounts using MeOH (Sigma Aldrich, Missouri, U.S.) and deionized water
(di H2O). Filters were first placed upside down inside a plastic beaker (with the collected samples
facing the bottom of the plastic beaker). 5 mL of 75% MeOH was added aseptically using a
serological pipette (following standard GSU safety measures and protocols), ensuring that the
MeOH completely covered each PTFE filter. Parafilm and aluminum foil coverings were then
placed onto the plastic beakers. Each PTFE filter was sonicated separately at 45% amplitude for
four minutes in an ice-water bath, continuously refilling the cup sonicator (Branson Ultrasonics
Sonifier S-250D, ThermoFisher, Massachusetts, U.S.) with ice as needed. Following cup
sonication, each sample was then transferred to a plastic 15 mL conical tube to be eventually frozen
at -80C until needed later for toxicological analyses. Before freezing samples, they were
vacufuged at 60C using the Eppendorf Vacufuge Plus (Eppendorf, Massachusetts, U.S.) for
approximately three hours (time spent vacufuging ranged from two hours to six hours) down to 5
microliters (L) of sample to eliminate any residual MeOH. PTFE filters were weighed again at
least twice after allowing them to dry in the desiccator for one day to determine the total mass
extracted (i.e., initial concentration). Extraction efficiencies (in %; Table 1) were calculated by
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subtracting the average post-extraction weight from the average post-collection weight, dividing
the minuend by the total particle mass collected (Table 1), and multiplying the quotient by 100%.
Extracted and vacufuged samples were then placed into a -80C freezer until experimentation. On
experimentation days, samples were taken out of the freezer and left to thaw at room temperature.
After each sample was thawed, they were sonicated in batches of five to seven samples at 45%
amplitude for four minutes to homogenize the sample mixtures in preparation for dilutions.

3.3 Multiple-Path Particle Dosimetry Model Dose and Dilution Calculations
The Multiple-Path Particle Dosimetry Model (MPPD version 3.04) was used to determine
the low (4 g/mL) and high (20 g/mL) doses for each sample. Assuming that individuals spend
nearly 0.86 hours per day for five days each week for 52 weeks commuting to work and being
stuck in traffic (Knoblauch, 2019) and engaging in recreational activities outside (U.S. Bureau of
Labor Statistics, 2020), this data was used to calculate the total amount of PM (g/cm2) reaching
the pulmonary region per alveolar area in an adult. Low concentrations (4 g/mL) represent
individuals going to work or spending time outside for 0.86 hours per day for five days each week
for one year, whereas high concentrations (20 g/mL) represent individuals going to work or
spending time outside for 0.86 hours per day for five days each week for five years.

The total amount of PM (g/cm2) reaching the pulmonary region was divided by 70 m2
(Dunhill, 1962) to obtain the mass of PM per alveolar area used to calculate the doses utilized in
the toxicological experiments. The quotient was then multiplied by the total surface area of one
well (0.33 cm2) in a 96-well plate used for growing the SAEC. For example, the total amount of
PM reaching the pulmonary region, 991 g/cm2, was divided by 70 m2, and the quotient was
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multiplied by 0.33 cm2 to obtain a final product of 0.00046719 gcm2 (i.e., approximately 0.0004
g) of PM in a single well. After determining the deposited mass for the pulmonary region, a doseresponse assessment was conducted using 0.0004 g/mL (as a starting dose), 0.04 g/mL, and 4
g/mL to determine the lowest-observed-adverse-effect level, or the LOAEL, which is the lowest
concentration that causes an adverse alteration in cell viability. A dose-response assessment, a
critical concept in toxicology and risk assessment, correlates a range of exposure doses or
concentrations to a spectrum of induced effects, such as reduced cellular viability. Lower doses
used within the dose-response assessment (i.e., 0.0004 g/mL, 0.04 g/mL) did not elicit a cell
response nor any alterations in cell viability (i.e., reductions in cell viability) following a 48-hour
exposure. From the dose-response assessment, it was determined that 4 g/mL was the LOAEL
and was used for each PM sample.

After the low and high doses were calculated using the MPPD program, PM stock solutions
were diluted in PneumaCultTM-Ex Plus media (STEMCELLTM Technologies, British Columbia,
Canada). Dilution calculations depended on the initial concentrations, which varied for each
sample based on the total PM mass collected in the field, and starting volumes, which were
typically 500 to 600 L (accounting for volume loss). Final volumes for the low and high doses
for the reference control were calculated using 500 g/mL as the starting concentration. Dilutions
were performed aseptically (following GSU safety measures and protocols) by placing the correct
volume of Ex Plus media into a plastic 15 mL conical tube, followed by the correct volume of
particle stock solution into the media inside the tube. Diluted PM stock solutions were stored in a
4C refrigerator until use.

21

3.4 SAE Cell Culture and Exposure
Small airway epithelial cells (SAEC; Lonza, Maryland, U.S.), which are targets in the
inhalation route of traffic-related UFP exposure, were cultured in T-75 flasks using Ex Plus media
ideal for SAEC to ensure colloidal stability and minimize agglomeration. SAEC were incubated
in a controlled atmosphere of 37C and 5% CO2 until PM exposure. For PM exposures, SAEC
were sub-cultured in 96-well plates at a density of 20,000 cells/mL and grown to 70-80%
confluency. Confluency refers to the percentage of the surface area of each well covered with
adherent cells. Previously prepared PM colloidal suspensions diluted in Ex Plus media were
administered to SAEC for a period of 48 hours. The PM concentrations were matched to MPPDcalculated inhaled doses, which were administered to the SAEC.

After performing sample dilutions to replicate the calculated concentrations and preparing
SAEC cultures, cultured cells were plated onto 96-well black plates (Corning Inc., New York,
U.S.). Each well received 100 L of particles containing exposure media, and each plate remained
in the incubator for a 48-hour exposure period until toxicological assays were performed. Negative
controls were prepared by using only Ex Plus media. Positive controls were prepared by diluting
1 L of hydrogen peroxide (H2O2) into 999 L of PBS (phosphate-buffered saline; STEMCELLTM
Technologies, British Columbia, Canada). A second dilution was completed by adding 38.7 L of
the first dilution into 1 mL of PBS, which was then added to the cells fifteen minutes before
beginning the assays. Blanks represented vehicle controls (i.e., MeOH solvent) and were prepared
using (v/v) doses similar to PM exposures for the solvent vehicle to control for any excess MeOH
present.
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A plastic 15 mL conical tube was weighed in a small glass beaker and tared to prepare the
reference control. The tube was then taken to a disinfected fume hood following GSU safety
measures and protocols. Approximately 1 milligram (mg) of diesel particulate matter (industrial
forklift, standard reference material 2975; National Institute of Standards and Technology [NIST],
Maryland, U.S.) was placed inside the plastic tube using a spatula and weighed again.
Approximately 1 mL of cell culture grade water (Corning Inc., New York, U.S.) was pipetted
aseptically into the plastic tube, ensuring that any debris was washed off the sides of the tube (final
concentration: 1 mg/mL). The tube, which contained a heterogenous mixture, was then sonicated
in a cup sonicator at 75% amplitude for three minutes. The sonicator was filled with ice and water,
securing the tube into place using tape. The reference control was stored in a 4C refrigerator until
use.

3.5 Toxicological Assays
3.5.1 Detecting Reactive Oxygen Species (ROS) Induction Using the CellROX® Assay
TRAP exposures produce ROS that exhibit lethal effects on viable, metabolically active
cells (i.e., SAEC). ROS generation and subsequent interactions were detected and visualized using
the CellROX® Oxidative Stress Orange Reagent (Invitrogen, California, U.S.), which localized in
the cells’ cytoplasm. After the cells were exposed to the various TRAP exposures, the reagent was
prepared by aseptically adding 10 L of the CellROX® Orange Reagent to 5 mL of PBS to create
a 5 M concentration, wrapping the plastic conical tube in aluminum foil until needed later. The
treatments were removed from the cells, which were then washed twice with 200 L of PBS. 50
L of the prepared reagent was added to each well, and the 96-well plate was covered in aluminum
foil and incubated for thirty minutes at 37C. Following incubation, the media was removed, and
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the cells were washed three times with 200 L of PBS. Finally, using the Cytation 1 Cell Imaging
Multi-Mode Reader (BioTekTM Instruments, Vermont, U.S.), the relative fluorescence intensities
were measured and imaged at an excitation/emission maxima of ~ 545/565 nanometers (nm).

3.5.2 Detecting Total Glutathione (GSH) Using the GSH Assay
GSH is an antioxidant typically found in eukaryotic cells, an endogenous cellular
metabolism component, and a tripeptide consisting of glycine, cysteine, and glutamic acid used to
indicate oxidative stress, as observed by declines in total cellular GSH. The GSH/GSSG-GloTM
Assay (Promega, Wisconsin, U.S.) is a luminescence-based assay that detects and quantifies total
glutathione (GSH and glutathione disulfide [GSSG] and GSSG levels as well as GSH-to-GSSG
ratios in cultured cells, which served as a quantitative validation for the CellROX® assay in this
study. 70 L of Luciferin-NT, 70 L of glutathione S-transferase (GST), and 7 mL of GSH/GSSGGloTM reaction buffer were added in a plastic 15 mL conical tube to prepare the GSH assay reagent.
After removing the PM exposures/supernatants from each well and transferring them to a new,
clean, and labeled 96-well plate, the cells were washed once with 200 L of PBS. 50 L of the
prepared GSH reagent was added to each well, and the 96-well plate was incubated for thirty
minutes. Then, 50 L of the Luciferin detection reagent was added to each well for fifteen minutes,
and the luminescence was measured within two hours using the Cytation 1 Cell Imaging MultiMode Reader.

3.5.3 Assessing Cellular Viability Using the MTS Assay
Cellular viability was assessed using a tetrazolium compound [3-(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] in the MTS
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colorimetric assay (CellTiter 96® AQueous One Solution, Promega, Wisconsin, U.S.). The MTS
assay detects the reduction of the MTS tetrazolium compound by viable mammalian cells to
generate a colored formazan dye that is soluble in cell culture media. This conversion is thought
to occur via NAD(P)H-dependent dehydrogenase enzymes in metabolically active cells. 777 L
of the MTS reagent was added into 6,223 L of Ex-Plus media inside of a plastic 15 mL conical
tube to prepare 7 mL of the MTS reagent (calculated using an 8x8 plating scheme in which 64
wells required 100 L of the MTS reagent to total to approximately 6,400 L of MTS reagent).
After removing the PM exposures/supernatants from each well and transferring them to a new,
clean, and labeled 96-well plate, the cells were washed once with 200 L of PBS. Once the MTS
reagent was added, the plate was placed inside the incubator for one to two hours. Absorbance
measurements were made using the Cytation 1 Cell Imaging Multi-Mode Reader at an
excitation/emission maximum of 490 nm. This same plate was also used for the GSH assay, also
known as sequenced multiplexing.

3.6 Evaluation of Pro-Inflammatory Cytokines
Supernatants from previous experiments were stored in a -80C freezer and used for
cytokine analyses using the Human Cytokine Array Proinflammatory Focused 15-plex (HDF15;
Eve Technologies, Alberta, Canada). The HDF15 was used to test for GM-CSF, IFN, IL-1, IL1ra, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12(p40), IL-12(p70), MCP-1, and TNF- using
selected samples. The HDF15 examines human cytokines and chemokines, a particular cytokine
type, using a multiplex immunoassay analyzed with a BioPlex 200 (Eve Technologies, 2021).
Cytokines are key inflammation modulators, participating in acute and chronic inflammation via
a complex network of interactions. Unlike hormones, cytokines act on a broader range of target
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cells and are not produced by specialized cells (Eve Technologies, 2021). Cytokines and
chemokines play an influential role in particle-mediated lung inflammation, such as that seen in
allergic reactions and fibrosis (Moldoveanu et al., 2009; Robinson et al., 1993). Selected samples
for cytokine analyses (Table 2) were prepared by centrifugation and were then aliquoted into 0.6
mL microcentrifuge tubes, labeled appropriately (T1 and T2 represent trials one and two,
respectively), and shipped on dry ice.

3.7 Statistical Analyses
All exposures were evaluated in duplicates, and at least three experiments were conducted
per toxicological assay. All data were normalized to the negative control and analyzed for
significance using a one-way ANOVA analysis followed by Tukey’s post-hoc test (α = 0.1)
utilizing GraphPad Prism software (Prism version 9.0.0). The one-way ANOVA analysis
involving Tukey’s post-hoc test included all ten treatment groups and the three control groups (i.e.,
negative control, positive control, low-dose reference control). P-values of less than or equal to
0.01 were deemed significant.

3.8 Materials and Reagents
The MeOH used to prepare 75% MeOH for PTFE filter extractions was purchased from
Sigma Aldrich (Missouri, U.S.). PneumaCultTM-Ex Plus media used to dilute PM stock solutions
and culture SAEC was purchased from STEMCELLTM Technologies (British Columbia, Canada).
SAEC were purchased from Lonza (Maryland, U.S.). 96-well black plates were purchased from
Corning Inc. (New York, U.S.). The PBS used to prepare the negative control and blanks during
toxicological experimentation was purchased from STEMCELLTM Technologies. The diesel
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particulate matter (industrial forklift, standard reference material 2975) used to prepare the
reference control was purchased from NIST (Maryland, U.S.). The cell culture grade water used
to dilute the reference control to a concentration of 1 mg/mL was purchased from Corning Inc.
(New York, U.S.).

The CellROX® Oxidative Stress Orange Reagent utilized during the CellROX® assay was
purchased from Invitrogen (California, U.S.). The MTS reagent was prepared using CellTiter 96®
AQueous One Solution purchased from Promega (Wisconsin, U.S.). The GSH/GSSG-GloTM Assay
reagent was prepared utilizing Luciferin-NT, GST, and the GSH/GSSG-GloTM reaction buffer
purchased from Promega (Wisconsin, U.S.).
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4. RESULTS
4.1 PTFE Filter Collection and Extraction Data
After the PTFE filters were reweighed following sample collection, the total particle mass
collected on each filter was calculated by subtracting the average post-collection weight from the
average pre-collection weight (in mg; Table 1). For example, sample TR2009 weighed 78.842 mg
before sample collection and weighed 78.8735 mg after sample collection, yielding 0.0315 mg of
total particle mass collected (Table 1). In addition to the particle mass collected for each sample
filter, Table 1 also shows at which site and on what date the filters were collected. Each filter’s
position at the sites (i.e., road or barrier) is also listed. Except for S1, every site featured a barrier
filter with less particle mass collected than the road filter. The average extraction efficiency
calculated using selected samples (Table 1) was approximately 80.754%, which excludes an
outlier (i.e., TR2009 with an extraction efficiency of roughly 479.365% likely due to a
measurement error). Even though TR2009 was excluded from the average extraction efficiency
calculations, it was still a valid measurement and was included in subsequent toxicological
analyses since the initial concentration was diluted to match the MPPD-derived dose (4 g/mL)
like the other samples. The average extraction efficiency calculated using barrier samples (i.e.,
TR2022, TR2034, TR2037) was 74.694% (median: 77.231%) compared to the average extraction
efficiency calculated using road samples (i.e., TR2011, TR2018, TR2019, TR2028, TR2030,
TR2032), which was 83.784% (median: 85.431%).

4.2 Reactive Oxygen Species (ROS) Generation
Images revealing cell populations and associated oxidative stress induced by ROS
production following the 48-hour exposures for specific samples were gathered (Figure 4). Figure
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4 displays representative images for the controls, blanks, and selected samples from S1, S3, and
S5 using the low dose (4 g/mL). The blue stain represents DAPI signaling, and the orange stain
represents Texas Red® signaling, which indicates oxidative stress via ROS generation. ROS
production results in downstream alteration of membrane lipids, proteins, and nucleic acids (e.g.,
DNA). Subsequent oxidative damage of these biomolecules relates to several pathological events,
including but not limited to respiratory illness (e.g., asthma, emphysema) and carcinogenesis.

The negative control does not exhibit any Texas Red® signaling, yet the positive and
reference controls do, indicating oxidative stress (Figure 4). The blank reveals limited oxidative
stress. Ideally, the negative control should reveal no oxidative stress, whereas positive controls
should exhibit the highest amount of oxidative stress present in the cell population, with reference
controls, blanks, and samples falling in between the negative and positive controls. Compared to
the negative control, road and barrier PM mass resulted in decreased cell populations due to
damaged and dying cells (Figure 4). When comparing road PM mass to barrier PM mass, however,
a common trend included diminished Texas Red® signaling (i.e., reduced oxidative stress)
observed following the barrier PM mass exposures. Samples TR2009 and TR2037 collected at S1
revealed increased oxidative stress compared to the other road-barrier pairs collected at S3 and S5.

4.3 Comparative Toxicological Assessments of PTFE Filter Extracted Mass
4.3.1 Low-Dose TRAP Exposures Elicit Oxidative Stress
Quantitative data summarizing antioxidant capacity using the GSH assay were gathered
using the low dose (4 g/mL; Figure 5). GSH regulates intracellular ROS by protecting cells
against the damaging effects of oxidative stress and facilitating ROS cell signaling. When a GSH
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imbalance occurs, the cell’s oxidative stress response changes to reflect the pathogenesis of several
adverse health outcomes, including asthma and fibrosis. Negative controls, positive controls, and
low-dose reference controls are represented by black, grey, and blue bars, respectively (Figure 5).
The x-axis represents the various treatment groups, whereas the y-axis represents percent control
(Figure 5). For total GSH, the green bars indicate barrier PM mass, whereas the orange bars
indicate road PM mass. Low doses using road PM mass did cause oxidative stress, as observed by
a reduction in GSH levels at S1 and S5 (i.e., TR2009, TR2032, respectively). Figure 5 shows that
barriers at these locations, however, reduced oxidative stress due to an increase in GSH levels (i.e.,
TR2037, TR2034, respectively).

4.3.2 The Impact of Low-Dose TRAP Exposures on Cellular Viability
Empirical data summarizing cellular viability using the MTS assay were gathered (Figure
5). NADPH-dependent dehydrogenase enzymes housed in the mitochondria induce the reduction
of the tetrazolium compound in the MTS reagent to a colored formazan dye. The mitochondria’s
ability to employ these enzymes decreases as cellular viability declines. Negative controls, positive
controls, and low-dose reference controls are represented by black, grey, and blue bars,
respectively (Figure 5). The x-axis represents the various treatment groups, whereas the y-axis
represents percent control (Figure 5). For cellular viability, the green bars indicate barrier PM
mass, whereas the orange bars indicate road PM mass. Due to the low dose used (4 g/mL), no
overt toxicity was observed at most of the sites selected. Overall, there was no reduction in cellular
viability at sites with barriers (e.g., S1, S3, S5), which compared barrier PM mass to road PM mass
(i.e., TR2009 versus TR2037; TR2022 versus TR2019; TR2034 versus TR2032, respectively). In
other words, most of the cells were still metabolically active and alive following the 48-hour
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exposure period. For the S2 front-road PM mass (i.e., TR2011), however, more cells were inviable,
indicating that cells either became damaged or died and could not metabolize the substrate – a
formazan product – during the MTS assay or died. It proves crucial to note here that S2 did not
contain barriers, only a chain-link fence between the service road and interstate (Figure 1). Barrier
PM mass collected at S1 (i.e., TR2037) exhibited higher toxicity than road PM mass collected at
the same site (i.e., TR2009; Figure 5).

4.4 Low-Dose TRAP Exposures Elicit Pro-inflammatory Cytokine Secretion
Increases in pro-inflammatory cytokines associated with airway inflammation were
observed (Figure 6). Additionally, green barriers reduced pro-inflammatory cytokine secretion at
specific sites (e.g., S3 and S5 for GM-CSF and TNF-α; S1, S3, and S5 for IL-8; and S1 and S5 for
MCP-1). Negative controls, positive controls, and low-dose reference controls are represented by
black, grey, and blue bars, respectively. The x-axis represents the various treatment groups,
whereas the y-axis represents concentration (Figure 5). Green bars indicate barrier PM mass,
whereas orange bars indicate road PM mass. Studies have indicated that GM-CSF likely
contributes to airway remodeling and plays a crucial role in the pathogenesis of asthma (Saha et
al., 2009). Barrier PM mass collected at S3 and S5 (i.e., TR2022, TR2034, respectively) resulted
in a significant decrease in GM-CSF concentrations compared to road PM mass collected at the
same sites (i.e., TR2019, TR2032, respectively; Figure 6A). Notably, the combination barrier
(trees and sound wall) at S3 provided adequate protection against TRAP, given this observed
reduction in GM-CSF concentrations. Even though a reduction in GM-CSF concentrations
between front- versus side-road PM mass collected at S2 and S4 (i.e., TR2011 versus 2018;
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TR2028 versus TR2030, respectively) was observed, this site contained no barriers (little to no
trees present).

IL-8 is a biomarker for uncontrolled asthma and is considered a significant chemotactic
factor, which involves neutrophil recruitment and activation (Ordoñez et al., 2000). It is also active
on primed eosinophils. Barrier PM mass collected at S1, S3, and S5 (i.e., TR2037, TR2022,
TR2034, respectively) resulted in a significant decrease in IL-8 concentrations compared to road
PM mass collected at the same sites (i.e., TR2009, TR2022, TR2034, respectively; Figure 6B). In
other words, any barrier type, such as a green or combination barrier, led to diminished IL-8
concentrations. The front-road PM mass collected at S2 (i.e., TR2011) exhibited decreased IL-8
concentrations than the side-road PM mass collected at the same site (i.e., TR2018).

Studies have indicated that monocyte chemotactic proteins (MCPs) in bronchoalveolar
fluid are associated with the rapid appearance of a monocyte-derived population of alveolar
macrophages (Lee et al., 2015). Barrier PM mass collected at S1 and S5 (i.e., TR2037, TR2034,
respectively) resulted in a significant decrease in MCP-1 concentrations compared to road PM
mass collected at the same sites (i.e., TR2009, TR2032, respectively; Figure 6C). Mainly, tree
barriers provided sufficient protection against TRAP, given this observed reduction in MCP-1
concentrations. The front-road PM mass collected at S2 (i.e., TR2011) revealed lower MCP-1
concentrations than the side-road PM mass collected at the same site (i.e., TR2018). Conversely,
the front-road PM mass collected at S4 (i.e., TR2028) exhibited higher MCP-1 concentrations than
the side-road PM mass collected at the same site (i.e., TR2030).
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TNF-α, a potent inflammatory cytokine, has been implicated in various pulmonary
diseases, including asthma and emphysema (Keatings et al., 1997; Lucey et al., 2002). Barrier PM
mass collected at S3 and S5 (i.e., TR2022, TR2034, respectively) resulted in a significant decrease
in TNF-α concentrations compared to road PM mass collected at the same sites (i.e., TR2019,
TR2032, respectively; Figure 6D). Unlike GM-CSF, however, the green barrier at S5 provided
adequate protection against TRAP, given this observed reduction in TNF-α concentration. Like
the other cytokines, the front-road PM mass collected at S2 (i.e., TR2011) exhibited decreased
TNF-α concentrations than the side-road PM mass collected at the same site (i.e., TR2018).
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5. DISCUSSION AND CONCLUSION
Low-level chronic doses of TRAP exposures may contribute to or exacerbate adverse
health outcomes, including but not limited to asthma and inflammation, over time (Cesaroni et al.,
2008; Guarnieri & Balmes, 2015; Huff, Carlsten, & Hirota, 2019; Landreman et al., 2008;
Neophytou et al., 2013; Xia, Kovochich, & Nel, 2006). This study examined the toxicological
profiles of traffic-related PM mass using SAEC to assess ROS generation, oxidative stress,
antioxidant capacity, cellular viability, and cytokine secretion. Limited knowledge exists regarding
green infrastructure and its influence on TRAP-mediated toxicological effects, and this study is
the first of its kind to demonstrate the potential human health benefits of green barriers along major
highways/roadways.

Site characteristics at S1 through S5 varied primarily based on barrier presence,
temperature, precipitation, roadway layout, and traffic volume. While barriers featured at S1 and
S5 included trees next to the major roadways, S2 and S4 did not have barriers, rather chain-link
fences between the sampling stations and roadways. A combination barrier at S3, which included
trees and a sound wall, was present. High temperatures (approximately 80-95F) were observed at
all examined sites. While sampling at S4 (i.e., on two different days: August 28 and September
10), the rain did not allow for a full day to gather data and collect PM mass. Regarding roadway
layout and resulting traffic volume, S1’s location was unique since two major roadways converge
into one major roadway, contributing to increased traffic levels in the area (Afrin & Yodo, 2020),
unlike the other examined sites. In addition to PM sampling using PTFE filters, extraction
efficiencies following gravimetric analysis of total PM mass, typically around 80% (Kumar et al.,
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2021), may correlate with the overall size distribution, indicating that smaller-sized particles are
usually extracted more efficiently than larger-sized particles (Chen, Ji, & Zhao, 2019).

PM collected at various sites, including but not limited to urban areas with continuous
traffic and stop-and-go traffic sites, has been shown to induce ROS generation (Li et al., 2003;
Mirowsky et al., 2015) and increase pro-inflammatory potential (Mirowsky et al., 2013; Steenhof
et al., 2011), especially in human lung epithelial cells (Li et al., 2002; Mazuryk, Stochel, &
Brindell, 2020; Shi et al., 2006). ROS production and associated oxidative stress detected in
selected barrier samples collected at S1, S3, and S5 revealed a reduction in ROS-induced oxidative
stress when compared to selected road samples collected at the same sites. Oxidative stress, which
refers to the imbalance between cellular antioxidants and oxidants, correlates with a cell’s
antioxidant capacity. Antioxidant capacity refers to a cell’s ability to combat the oxidative damage
done to it following a decline in the cellular GSH-to-GSSG ratio, which regulates and maintains
redox balance (Li, Xia, & Nel, 2008). Changes in the GSH-to-GSSG ratio due to ROS production
(Xia, Kovochich, & Nel, 2006) could initiate these stress responses that may injure the cells (Li,
Xia, & Nel, 2008; Xia, Kovochich, & Nel, 2006). The oxidative potential of PM, or its ability to
oxidize target molecules and exacerbate the imbalance between antioxidants and oxidants in favor
of the latter, typically increased at sites with continuous traffic (Janssen et al., 2014). S1 samples
TR2009 and TR2037 exhibited increased oxidative stress overall compared to other road-barrier
pairs, likely due to S1’s location and subsequent traffic volume.

Since limited sample concentrations were observed overall, it proved challenging to
compare samples collected on the same day at the same site, specifically for S1 samples TR2009

35

and TR2037 as well as S2 samples TR2011 and TR2018. TR2037 was collected in September
(compared to TR2009, which was collected in July), and the observed difference in ROS
generation and resulting oxidative stress could have occurred due to varying traffic levels and
temperature differences between those two months. Similarly, TR2011 was collected in late July
(compared to TR2018, which was collected in early August), and the observed difference in
oxidative stress could have occurred due to differing traffic levels between sampling days at S2.
Low toxicity observed at most of the selected sites likely corresponded with low traffic volume
present at each site (except for S1).

Observed oxidative stress in the collected CellROX® images complements the GSH and
MTS assay data summarizing antioxidant capacity and cellular viability, respectively. Declines in
total GSH levels observed in the road zones suggest an increase in oxidative stress caused by the
low dose (4 g/mL). Conversely, increases in GSH levels correspond with a reduction in oxidative
stress, as observed in the barrier zones. As cellular ROS concentrations increase, antioxidant
capacity typically declines, resulting in oxidative stress and an overall decrease in cellular viability
for specific exposure durations (Huff, Carlsten, & Hirota, 2019; Landreman et al., 2008; Leikauf,
Kim, & Jang, 2020). When traffic-related UFPs deposit in the airways, ROS production and
oxidant-mediated cellular damage can occur, which can lead to adverse health effects (Huff,
Carlsten, & Hirota, 2019; Leikauf, Kim, & Jang, 2020). Although changes in GSH levels occurred,
a reduction in cellular viability at S1, S3, and S5 was not observed, indicating that the cell
populations were still alive and metabolically active. Unlike the road PM mass collected at these
sites, cells did not die or become damaged as often when exposed to barrier PM mass collected at
these same sites. Following exposures using front-road PM mass collected at S2, the cells could
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not survive the TRAP exposures at the dose and exposure duration. A decrease in cellular viability
relates to an increase in TRAP-induced mechanisms, such as ROS production and oxidative (Cho
et al., 2018; Lu et al., 2015). Generally, PM mass collected in the barrier zones did not reduce
cellular viability as much as PM mass collected in the road zones, revealing the potential green
infrastructure displays towards reducing TRAP-mediated respiratory effects.

Cellular cytokines and chemokines, which serve as modulators in TRAP-induced lung
inflammation, increase in concentration in response to particle exposures and either solely employ
inflammatory cells (e.g., IL-8) or recruit additional cytokines and chemokines or macrophages
(e.g., TNF-α; Driscoll et al., 1997). Cytokine analyses that measured GM-CSF, IL-8, MCP-1, and
TNF-α concentrations revealed that barrier TRAP did not elicit higher levels of cytokines than
road TRAP. In other words, the cells secreted fewer cytokines in response to toxic insults using
barrier PM mass. Leikauf, Kim, and Jang reported that UFP exposures promote cytokine secretion,
especially for GM-CSF, IL-8, and TNF-α (2020). Generally, any barrier type (i.e., green or
combination barrier) protected against TRAP, given observed reductions in GM-CSF, IL-8, MCP1, and TNF-α concentrations. Interestingly, the barrier PM mass collected at S1 revealed increased
GM-CSF and TNF-α concentrations compared to the road PM mass. These observed decreases in
cytokine secretion complement the qualitative data the CellROX® assay provided and quantitative
data the GSH assay provided. Viable and metabolically active cells with undisturbed antioxidant
capacity do not secrete pro-inflammatory cytokines, whereas injured cells do (Leikauf, Kim, &
Jang, 2020; Wieczfinska et al., 2019). Observed GSH levels as well as observed GM-CSF, IL-8,
MCP-1, and TNF-α concentrations indicated that green barriers reduced TRAP-mediated effects
on antioxidant capacity and cytokine secretion, respectively, in SAEC. Similarly, observed GM-
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CSF, IL-8, and TNF-α concentrations revealed a combination barrier reduced TRAP-induced
effects on cytokine secretion in SAEC.

Although this study offers preliminary evidence regarding PM exposures and how they can
impact human cells, there are study limitations. Limited sample mass collection prevented
assessment of cellular toxicity for identical days (especially at S1 and S2), which may have
intervened with the cellular effects observed following exposures to PM collected at the examined
sites. Due to the COVID-19 pandemic, reduced regional traffic levels led to decreased TRAP
concentrations in the Atlanta area. Further analyses of this data should include data on traffic
volume for each site. Similarly, the occurrence of rainfall impeded the collection of specific
samples for a full day (approximately six hours) during the sampling campaign. These analyses do
not include a full analysis of meteorological conditions, such as wind direction and windspeed,
known to affect pollutant concentrations close to roadways.

In conclusion, green infrastructure may play a role in mitigating TRAP-mediated
respiratory health effects. Over time, green barriers may lessen the toxicological impact caused by
low-level chronic doses and reduce the occurrence of respiratory outcomes (e.g., inflammation).
As urbanization continues, strategies to reduce exposures to motor vehicle emissions, such as
installing porous and solid barriers, remain a top priority. Exploring the toxicological effects of
traffic-related UFPs can offer valuable information regarding the mechanisms involved in TRAPassociated health effects and can be used in conjunction with continuous PM data and speciation.
Investigating the mechanisms behind ROS generation, oxidative stress, antioxidant capacity,
cellular viability, and cytokine secretion can also help understand TRAP-mediated health effects.
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This study provides evidence to conduct future experiments regarding green infrastructure and its
impact on traffic-related UFP exposures utilizing refined methodologies.
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TABLES

Table 1. Collected and Extracted Particle Mass Using
Selected Sample Filters

Site ID

Date
Collected

PTFE
Filter ID

Road versus
Barrier

S1
S1
S2
S2
S3
S3
S4
S4
S5
S5

7/24/20
9/3/20
7/28/20
8/7/20
8/20/20
8/20/20
8/28/20
8/28/20
9/1/20
9/1/20

TR2009
TR2037
TR2011
TR2018
TR2019
TR2022
TR2028
TR2030
TR2032
TR2034

Road
Barrier
NA (Front-Road)
NA (Side-Road)
Road
Barrier
NA (Front-Road)
NA (Side-Road)
Road
Barrier
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Particle
Mass
Collected
(mg)
0.0315
0.1625
0.4895
0.1655
0.1175
0.054
0.0505
0.028
0.0415
0.015

Particle
Mass
Extracted
(mg)
0.151
0.1255
0.425
0.149
0.1
0.0325
0.043
0.024
0.029
0.013

Extraction
Efficiency
(%)
479.3650794
77.23076923
86.82328907
90.03021148
85.10638298
60.18518519
85.14851485
85.71428571
69.87951807
86.66666667

Table 2. Selected Samples Sent to Eve Technologies for
Cytokine Analyses (HDF15)
Site ID

Date Collected

ET Sample ID (T1)

ET Sample ID (T2)

Road versus Barrier

S1
S1
S1
S1
S1
S1
S2
S2
S2
S3
S3
S4
S4
S5
S5
S5
S5
S1

7/17/20
7/22/20
7/24/20
7/24/20
9/3/20
9/3/20
7/28/20
7/28/20
8/7/20
8/20/20
8/20/20
8/28/20
8/28/20
8/27/20
8/27/20
9/1/20
9/1/20
7/22/20

2004L T1
2005L T1
2008L T1
2009L T1
2035L T1
2037L T1
2011L T1
2014L T1
2018L T1
2019L T1
2022L T1
2028L T1
2030L T1
2023L T1
2025L T1
2032L T1
2034L T1
FB2001 T1
NC T1
PC T1
RL T1
BL T1

2004L T2
2005L T2
2008L T2
2009L T2
2035L T2
2037L T2
2011L T2
2014L T2
2018L T2
2019L T2
2022L T2
2028L T2
2030L T2
2023L T2
2025L T2
2032L T2
2034L T2
FB2001 T2
NC T2
PC T2
RL T2
BL T2

Barrier
Barrier
Barrier
Road
Road
Barrier
NA (Front-Road)
NA (Side-Road)
NA (Side-Road)
Road
Barrier
NA (Front-Road)
NA (Side-Road)
Road
Barrier
Road
Barrier
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FIGURES

Figure 1. Mobile Cart Featuring Continuous
Instrumentation at S2
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Figure 2. Cascade Particle Impactor and Weather Station
Set-up at S1
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Figure 3. Map of All Site Locations (S1-S5) in Atlanta, GA
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Figure 4. Reactive Oxygen Species Generation After 48Hour Exposure Using CellROX® Images for S1, S3, and S5
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Figure 5. The Impact of TRAP on Oxidative Stress in Small
Airway Epithelial Cells and Corresponding Cell Viability
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Figure 6. Modulation of Pro-Inflammatory Cytokines Due to
Barrier and Road TRAP
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